MNOV
MEDICINOVA INC
Key Financials
Operating Income
$-13283002
↓ 4.8%
Net Income
$-11997957
↓ 8.6%
Revenue
$409657
↓ 59.0%
Total Assets
$45.6M
↓ 18.4%
EPS (Diluted)
$-0.24
↓ 4.3%
Total Liabilities
$4.0M
↑ 19.1%
Cash & Equivalents
$30.8M
↓ 23.7%
Shareholders' Equity
$41.6M
↓ 20.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/29/2026 | View on SEC |
| SCHEDULE 13D/A | 9/29/2026 | View on SEC |
| 8-K | 9/28/2026 | View on SEC |
| 8-K | 9/2/2026 | View on SEC |
| 8-K | 8/19/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 8-K | 6/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MNOV |
| Company Name | MEDICINOVA INC |
| CIK | 1226616 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-373-1500 |